Skip to content
CancerIndex

Publication

TMB as a predictive biomarker for ICI response in TNBC: current evidence and future directions for augmented anti-tumor responses.

Authors not recorded

Clin Exp Med2025PMID 41249701PMC12628467stubpubmedProvenance
Source
PubMed
Retrieved
Sep 10, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260910-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 3

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
41249701
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
High2
Immune Checkpoint InhibitorTriple-Negative Breast CarcinomaALIASPredictiveESupports N/A3submitted
EID12950

This review synthesizes current preclinical, translational, and clinical evidence evaluating tumor mutational burden (TMB) as a predictive biomarker for immune checkpoint inhibitor (ICI) response in t… (full text at CIViC)

PMID 41249701 · Das et al., 2025 · Open in CIViC

civic
〃Triple-Negative Breast CarcinomaALIASPredictiveESupports Sensitivity Response2accepted
EID13213

TMB is being investigated as a predictive biomarker for response to immune checkpoint inhibitors (ICIs) in triple-negative breast cancer (TNBC). TMB is defined as the number of somatic mutations per m… (full text at CIViC)

PMID 41249701 · Das et al., 2025 · Open in CIViC

civic